Trial record 9 of 46 for:
Taclonex | psoriasis
An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01982552 |
|
Recruitment Status :
Completed
First Posted : November 13, 2013
Last Update Posted : February 2, 2018
|
Sponsor:
LEO Pharma
Information provided by (Responsible Party):
LEO Pharma
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | January 2014 |
| Actual Study Completion Date : | January 2014 |